Archives of Neuroscience

Published by: Kowsar

Review of Toxoplasmic Encephalitis in HIV Infection; a Case Study

Alireza Baratloo 1 , Behrooz Hashemi 1 , Alaleh Rouhipour 2 , * , Pauline Haroutunian 3 and Maryam Mahdlou 4
Authors Information
1 Department of Emergency Medicine, Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran.
2 Department of Pediatrics, Valeeasr Hospital, Ghazvin University of Medical Sciences, Abyek, IR Iran.
3 Department of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
4 Department of Internal Medicine, Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran.
Article information
  • Archives of Neuroscience: April 01, 2015, 2 (2); e20891
  • Published Online: April 1, 2015
  • Article Type: Case Report
  • Received: June 9, 2014
  • Accepted: August 26, 2014
  • DOI: 10.5812/archneurosci.20891

To Cite: Baratloo A, Hashemi B, Rouhipour A, Haroutunian P, Mahdlou M. Review of Toxoplasmic Encephalitis in HIV Infection; a Case Study, Arch Neurosci. 2015 ; 2(2):e20891. doi: 10.5812/archneurosci.20891.

Copyright © 2015, Tehran University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
  • 1. He J, Chen Y, Farzan M, Choe H, Ohagen A, Gartner S, et al. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature. 1997; 385(6617): 645-9[DOI][PubMed]
  • 2. Premack BA, Schall TJ. Chemokine receptors: gateways to inflammation and infection. Nat Med. 1996; 2(11): 1174-8[PubMed]
  • 3. Mindel A, Tenant-Flowers M. ABC of AIDS: Natural history and management of early HIV infection. BMJ. 2001; 322(7297): 1290-3[PubMed]
  • 4. Rogers G, Anne M, Alan B. Signs and symptoms of chronic HIV disease. HIV, viral hepatitis and STIs. 2008; 63(1)
  • 5. McArthur JC, Brew BJ, Nath A. Neurological complications of HIV infection. Lancet Neurol. 2005; 4(9): 543-55[DOI][PubMed]
  • 6. Montoya JG,, Remington JS. Principles and Practice of Infectious Diseases. 2000; : 2858-2888
  • 7. Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis. 1992; 15(2): 211-22[PubMed]
  • 8. Navia BA, Petito CK, Gold JW, Cho ES, Jordan BD, Price RW. Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients. Ann Neurol. 1986; 19(3): 224-38[DOI][PubMed]
  • 9. Renold C, Sugar A, Chave JP, Perrin L, Delavelle J, Pizzolato G, et al. Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome. Medicine (Baltimore). 1992; 71(4): 224-39[PubMed]
  • 10. Gray F, Gherardi R, Wingate E, Wingate J, Fenelon G, Gaston A, et al. Diffuse "encephalitic" cerebral toxoplasmosis in AIDS. Report of four cases. J Neurol. 1989; 236(5): 273-7[PubMed]
  • 11. Rabaud C, May T, Amiel C, Katlama C, Leport C, Ambroise-Thomas P, et al. Extracerebral toxoplasmosis in patients infected with HIV. A French National Survey. Medicine (Baltimore). 1994; 73(6): 306-14[PubMed]
  • 12. Wallace MR, Rossetti RJ, Olson PE. Cats and toxoplasmosis risk in HIV-infected adults. JAMA. 1993; 269(1): 76-7[PubMed]
  • 13. Porter SB, Sande MA. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med. 1992; 327(23): 1643-8[DOI][PubMed]
  • 14. San-Andres FJ, Rubio R, Castilla J, Pulido F, Palao G, de Pedro I, et al. Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 1115 patients infected with human immunodeficiency virus, 1989-1997. Clin Infect Dis. 2003; 36(9): 1177-85[DOI][PubMed]
  • 15. Levy RM, Janssen RS, Bush TJ, Rosenblum ML. Neuroepidemiology of acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr. 1988; 1(1): 31-40[PubMed]
  • 16. Grant IH, Gold JW, Rosenblum M, Niedzwiecki D, Armstrong D. Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS. AIDS. 1990; 4(6): 519-21[PubMed]
  • 17. Luft BJ, Brooks RG, Conley FK, McCabe RE, Remington JS. Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome. JAMA. 1984; 252(7): 913-7[PubMed]
  • 18. Post MJ, Kursunoglu SJ, Hensley GT, Chan JC, Moskowitz LB, Hoffman TA. Cranial CT in acquired immunodeficiency syndrome: spectrum of diseases and optimal contrast enhancement technique. AJR Am J Roentgenol. 1985; 145(5): 929-40[DOI][PubMed]
  • 19. Levy RM, Rosenbloom S, Perrett LV. Neuroradiologic findings in AIDS: a review of 200 cases. AJR Am J Roentgenol. 1986; 147(5): 977-83[DOI][PubMed]
  • 20. Levy RM, Mills CM, Posin JP, Moore SG, Rosenblum ML, Bredesen DE. The efficacy and clinical impact of brain imaging in neurologically symptomatic AIDS patients: a prospective CT/MRI study. J Acquir Immune Defic Syndr. 1990; 3(5): 461-71[PubMed]
  • 21. Ciricillo SF, Rosenblum ML. Use of CT and MR imaging to distinguish intracranial lesions and to define the need for biopsy in AIDS patients. J Neurosurg. 1990; 73(5): 720-4[DOI][PubMed]
  • 22. Ciricillo SF, Rosenblum ML. Imaging of solitary lesions in AIDS. J Neurosurg. 1991; 74(6): 1029[PubMed]
  • 23. Dina TS. Primary central nervous system lymphoma versus toxoplasmosis in AIDS. Radiology. 1991; 179(3): 823-8[DOI][PubMed]
  • 24. O'Malley JP, Ziessman HA, Kumar PN, Harkness BA, Tall JG, Pierce PF. Diagnosis of intracranial lymphoma in patients with AIDS: value of 201TI single-photon emission computed tomography. AJR Am J Roentgenol. 1994; 163(2): 417-21[DOI][PubMed]
  • 25. Skiest DJ, Erdman W, Chang WE, Oz OK, Ware A, Fleckenstein J. SPECT thallium-201 combined with Toxoplasma serology for the presumptive diagnosis of focal central nervous system mass lesions in patients with AIDS. J Infect. 2000; 40(3): 274-81[DOI][PubMed]
  • 26. Hoffman JM, Waskin HA, Schifter T, Hanson MW, Gray L, Rosenfeld S, et al. FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS. J Nucl Med. 1993; 34(4): 567-75[PubMed]
  • 27. Pierce MA, Johnson MD, Maciunas RJ, Murray MJ, Allen GS, Harbison MA, et al. Evaluating contrast-enhancing brain lesions in patients with AIDS by using positron emission tomography. Ann Intern Med. 1995; 123(8): 594-8[PubMed]
  • 28. Jones JL, Hanson DL, Dworkin MS, Alderton DL, Fleming PL, Kaplan JE, et al. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997. MMWR CDC Surveill Summ. 1999; 48(2): 1-22[PubMed]
  • 29. Brodt HR, Kamps BS, Gute P, Knupp B, Staszewski S, Helm EB. Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS. 1997; 11(14): 1731-8[PubMed]
  • 30. Abgrall S, Rabaud C, Costagliola D, Clinical Epidemiology Group of the French Hospital Database on HIV. Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era. Clin Infect Dis. 2001; 33(10): 1747-55[DOI][PubMed]
  • 31. Luft BJ, Hafner R, Korzun AH, Leport C, Antoniskis D, Bosler EM, et al. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team. N Engl J Med. 1993; 329(14): 995-1000[DOI][PubMed]
  • 32. Carlos S, Subauste MD. Case Western Reserve University. 2006;
  • 33. Koppen S, Grunewald T, Jautzke G, Gottschalk J, Pohle HD, Ruf B. Prevention of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus infected patients: a clinical approach comparing aerosolized pentamidine and pyrimethamine/sulfadoxine. Clin Investig. 1992; 70(6): 508-12[PubMed]
  • 34. Schurmann D, Bergmann F, Albrecht H, Padberg J, Wunsche T, Grunewald T, et al. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection. Eur J Clin Microbiol Infect Dis. 2002; 21(5): 353-61[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments